SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna shares are oscillating as investors weigh the significant milestone of the first FDA-approved mRNA flu vaccine against concerns over potential executive orders targeting vaccination policy. The community remains deeply divided, with discussions intensely focused on balancing the company's innovation in oncology and infectious disease platforms against political regulatory risks and ongoing debates regarding vaccine safety.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending following a major custom-chip partnership with Google, which includes the issuance of a significant share warrant to support the TPU AI ecosystem. The stock is seeing heavy community debate as traders split between bullish optimism over long-term AI infrastructure contracts and bearish concerns regarding high volatility and macro-driven sell-offs.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is experiencing significant selling pressure as investors weigh concerns over a massive off-balance sheet financing structure tied to its AI infrastructure and reports of a critical security vulnerability in its VMware software. While the community is debating whether this dip represents an institutional shakeout or a fundamental shift in market sentiment, many bulls are using the pullback as a buying opportunity, pointing to the company's strong AI revenue growth and historical resilience ahead of upcoming earnings.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is trending due to positive Phase 3 results for its personalized mRNA cancer vaccine, intismeran, in combination with Keytruda, fueling investor enthusiasm for personalized oncology treatments. Community discussion is focused on the potential market expansion for individualized neoantigen therapies and the strategic importance of this validation for Merck's ongoing pipeline growth.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is experiencing heightened volatility as the community remains deeply divided, focusing on the company's recent operational updates and the broader political controversy surrounding the brand. Investors are actively debating the stock's future amid intense speculation regarding the company's long-term business viability and its role within the current political landscape.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF (XBI) is trending as the biotech sector gains momentum from positive clinical trial results for Moderna and Merck, sparking excitement about potential breakthroughs and increased M&A activity. Community discussion is heavily focused on the implications of these developments for the broader sector, with many investors actively debating buyouts, accumulation strategies, and the potential for a sector-wide rally.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is trending as investors digest a strong earnings beat and raised full-year guidance that signals a successful turnaround, though the stock faced volatility as traders weighed these results against broader consumer spending concerns and one-time tariff benefits. The community is actively debating the durability of the retailer's recovery, with many focused on whether the company can maintain its positive momentum in high-margin categories amidst persistent macro headwinds.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant market interest and price volatility as investors debate the impact of its pending acquisition of Personalis, which aims to secure a stronger position in the cancer recurrence monitoring market. The community remains divided, with some investors focusing on the company's long-term potential in AI-driven precision medicine and high short interest fueling speculation of a possible squeeze, while others express caution regarding potential dilution and ongoing insider selling.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is facing intense volatility as the market digests a massive $4.5 billion convertible debt offering, sparking a heated debate between retail investors anticipating aggressive expansion and skeptics concerned about dilution and long-term profitability. While the recent approval of a major New Jersey data center project has provided a fundamental floor, the stock remains a focal point for intense conflict between bullish proponents of AI infrastructure growth and bearish traders betting on a valuation correction.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM Integrated Shipping is trending as shareholders react to a new, unsolicited $37.50 per share bid from an Israeli group, which challenges the existing $35 Hapag-Lloyd merger agreement. The community is actively debating the likelihood of a bidding war, the potential for government intervention via Israel's 'golden share,' and the possibility of receiving substantial dividends while the transaction process unfolds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$GPRO woodman can yay or nay this here, that&#39;s what the shorts are not comprehending. This is unique because he owns so much of the company. Next $GME he doesn&#39;t need a board or shareholders to approve. STUPID SHORTS

$GPRO 

GoPro executives  incented to sell vs chap 11

StockTwits for iOS

GoPro Inc

Zoomlik

StockTwits Web

GameStop Corp

 woodman can yay or nay this here, that's what the shorts are not comprehending. This is unique because he owns so much of the company. Next 

 he doesn't need a board or shareholders to approve. STUPID SHORTS

Private

@EpicComeback 

Am thinking $2.5 a share.  What do you think ?

 

Am thinking $2.5 a share.  What do you think ?

@zoomlik isn&#39;t that only $461M?  I am thinking way more.

 isn't that only $461M?  I am thinking way more.